| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| QDEL - Quidel Corporation | HOLD | 0 @ USD 29.26 | USD 0 | The current share valuation price of QDEL based on adjusted close was USD 29.26. The average price that QDEL shares were previous bought at was USD 34.2088. The current market price is -14.5% lower than average price they were purchased at. The value of the holding in QDEL has increased by USD 1,525 compared to the previous valuation of Quidel Corporation however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| LMAT - LeMaitre Vascular Inc | HOLD | 0 @ USD 86.5399 | USD 0 | The current share valuation price of LMAT based on adjusted close was USD 86.5399. The average price that LMAT shares were previous bought at was USD 88.3616. The current market price is -2.1% lower than average price they were purchased at. The value of the holding in LMAT has fallen by USD 2,600 compared to the previous valuation of LeMaitre Vascular Inc |
| MASI - Masimo Corporation | HOLD | 0 @ USD 134.8 | USD 0 | The current share valuation price of MASI based on adjusted close was USD 134.8. The average price that MASI shares were previous bought at was USD 154.243. The current market price is -12.6% lower than average price they were purchased at. The value of the holding in MASI has fallen by USD 27,935 compared to the previous valuation of Masimo Corporation |
| MDT - Medtronic PLC | HOLD | 0 @ USD 101.65 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 101.65. The average price that MDT shares were previous bought at was USD 90.1172. The current market price is 12.8% higher than average price they were purchased at. The value of the holding in MDT has fallen by USD 223,994 compared to the previous valuation of Medtronic PLC |
| NVCR - Novocure Ltd | HOLD | 0 @ USD 10.03 | USD 0 | The current share valuation price of NVCR based on adjusted close was USD 10.03. The average price that NVCR shares were previous bought at was USD 17.5841. The current market price is -43.0% lower than average price they were purchased at. The value of the holding in NVCR has fallen by USD 1,562 compared to the previous valuation of Novocure Ltd |
| NVST - Envista Holdings Corp | HOLD | 0 @ USD 29.36 | USD 0 | The current share valuation price of NVST based on adjusted close was USD 29.36. The average price that NVST shares were previous bought at was USD 19.3259. The current market price is 51.9% higher than average price they were purchased at. The value of the holding in NVST has increased by USD 5,929 compared to the previous valuation of Envista Holdings Corp however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| OFIX - Orthofix Medical Inc | HOLD | 0 @ USD 13.0599 | USD 0 | The current share valuation price of OFIX based on adjusted close was USD 13.0599. The average price that OFIX shares were previous bought at was USD 15.391. The current market price is -15.1% lower than average price they were purchased at. The value of the holding in OFIX has increased by USD 1,570 compared to the previous valuation of Orthofix Medical Inc however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| OMCL - Omnicell Inc | HOLD | 0 @ USD 36.5 | USD 0 | The current share valuation price of OMCL based on adjusted close was USD 36.5. The average price that OMCL shares were previous bought at was USD 35.3385. The current market price is 3.3% higher than average price they were purchased at. The value of the holding in OMCL has fallen by USD 3,513 compared to the previous valuation of Omnicell Inc |
| PEN - Pennant International Group plc | HOLD | 0 @ USD 339.05 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 339.05. The average price that PEN shares were previous bought at was USD 263.725. The current market price is 28.6% higher than average price they were purchased at. The value of the holding in PEN has fallen by USD 10,742 compared to the previous valuation of Pennant International Group plc |
| PEN - PBF Energy Inc | HOLD | 0 @ USD 339.05 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 339.05. The average price that PEN shares were previous bought at was USD 263.725. The current market price is 28.6% higher than average price they were purchased at. The value of the holding in PEN has fallen by USD 10,742 compared to the previous valuation of PBF Energy Inc |
| PODD - Insulet Corporation | HOLD | 0 @ USD 245.57 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 245.57. The average price that PODD shares were previous bought at was USD 292.855. The current market price is -16.1% lower than average price they were purchased at. The value of the holding in PODD has increased by USD 35,709 compared to the previous valuation of Insulet Corporation however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| PRCT - Procept Biorobotics Corp | HOLD | 0 @ USD 29.21 | USD 0 | The current share valuation price of PRCT based on adjusted close was USD 29.21. The average price that PRCT shares were previous bought at was USD 58.0647. The current market price is -49.7% lower than average price they were purchased at. The value of the holding in PRCT has increased by USD 3,624 compared to the previous valuation of Procept Biorobotics Corp however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| LIVN - LivaNova PLC | HOLD | 0 @ USD 65.74 | USD 0 | The current share valuation price of LIVN based on adjusted close was USD 65.74. The average price that LIVN shares were previous bought at was USD 49.0651. The current market price is 34.0% higher than average price they were purchased at. The value of the holding in LIVN has fallen by USD 6,326 compared to the previous valuation of LivaNova PLC |
| RMD - ResMed Inc | HOLD | 0 @ USD 275.96 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 275.96. The average price that RMD shares were previous bought at was USD 245.187. The current market price is 12.6% higher than average price they were purchased at. The value of the holding in RMD has increased by USD 88,410 compared to the previous valuation of ResMed Inc however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| SIBN - Si-Bone Inc | HOLD | 0 @ USD 15.39 | USD 0 | The current share valuation price of SIBN based on adjusted close was USD 15.39. The average price that SIBN shares were previous bought at was USD 15.543. The current market price is -1.0% lower than average price they were purchased at. The value of the holding in SIBN has fallen by USD 1,018 compared to the previous valuation of Si-Bone Inc |
| STE - STERIS plc | HOLD | 0 @ USD 245.4 | USD 0 | The current share valuation price of STE based on adjusted close was USD 245.4. The average price that STE shares were previous bought at was USD 231.179. The current market price is 6.2% higher than average price they were purchased at. The value of the holding in STE has fallen by USD 92,585 compared to the previous valuation of STERIS plc |
| SYK - Stryker Corporation | HOLD | 0 @ USD 356.08 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 356.08. The average price that SYK shares were previous bought at was USD 373.721. The current market price is -4.7% lower than average price they were purchased at. The value of the holding in SYK has fallen by USD 106,270 compared to the previous valuation of Stryker Corporation |
| TFX - Teleflex Incorporated | HOLD | 0 @ USD 106.21 | USD 0 | The current share valuation price of TFX based on adjusted close was USD 106.21. The average price that TFX shares were previous bought at was USD 140.949. The current market price is -24.6% lower than average price they were purchased at. The value of the holding in TFX has fallen by USD 13,578 compared to the previous valuation of Teleflex Incorporated |
| TMDX - TransMedics Group Inc | HOLD | 0 @ USD 136.34 | USD 0 | The current share valuation price of TMDX based on adjusted close was USD 136.34. The average price that TMDX shares were previous bought at was USD 94.9988. The current market price is 43.5% higher than average price they were purchased at. The value of the holding in TMDX has increased by USD 6,069 compared to the previous valuation of TransMedics Group Inc however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| TNDM - Tandem Diabetes Care Inc | HOLD | 0 @ USD 18.89 | USD 0 | The current share valuation price of TNDM based on adjusted close was USD 18.89. The average price that TNDM shares were previous bought at was USD 21.0069. The current market price is -10.1% lower than average price they were purchased at. The value of the holding in TNDM has fallen by USD 2,710 compared to the previous valuation of Tandem Diabetes Care Inc |
| VREX - Varex Imaging Corp | HOLD | 0 @ USD 14.0399 | USD 0 | The current share valuation price of VREX based on adjusted close was USD 14.0399. The average price that VREX shares were previous bought at was USD 11.4631. The current market price is 22.5% higher than average price they were purchased at. The value of the holding in VREX has increased by USD 221 compared to the previous valuation of Varex Imaging Corp however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 89.73 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 89.73. The average price that ZBH shares were previous bought at was USD 101.487. The current market price is -11.6% lower than average price they were purchased at. The value of the holding in ZBH has fallen by USD 4,980 compared to the previous valuation of Zimmer Biomet Holdings Inc |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 76.8 | USD 0 | The current share valuation price of EW based on adjusted close was USD 76.8. The average price that EW shares were previous bought at was USD 73.8603. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in EW has fallen by USD 154,852 compared to the previous valuation of Edwards Lifesciences Corp |
| AORT - Artivion Inc | HOLD | 0 @ USD 39.61 | USD 0 | The current share valuation price of AORT based on adjusted close was USD 39.61. The average price that AORT shares were previous bought at was USD 35.2114. The current market price is 12.5% higher than average price they were purchased at. The value of the holding in AORT has increased by USD 116 compared to the previous valuation of Artivion Inc however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| ATEC - Alphatec Holdings Inc | HOLD | 0 @ USD 13.51 | USD 0 | The current share valuation price of ATEC based on adjusted close was USD 13.51. The average price that ATEC shares were previous bought at was USD 13.4027. The current market price is 0.8% higher than average price they were purchased at. The value of the holding in ATEC has fallen by USD 4,913 compared to the previous valuation of Alphatec Holdings Inc |
| ATRC - AtriCure Inc | HOLD | 0 @ USD 36.92 | USD 0 | The current share valuation price of ATRC based on adjusted close was USD 36.92. The average price that ATRC shares were previous bought at was USD 35.7294. The current market price is 3.3% higher than average price they were purchased at. The value of the holding in ATRC has fallen by USD 1,311 compared to the previous valuation of AtriCure Inc |
| AXGN - Axogen Inc | HOLD | 0 @ USD 33.9299 | USD 0 | The current share valuation price of AXGN based on adjusted close was USD 33.9299. The average price that AXGN shares were previous bought at was USD 18.8849. The current market price is 79.7% higher than average price they were purchased at. The value of the holding in AXGN has fallen by USD 6,593 compared to the previous valuation of Axogen Inc |
| BAX - Baxter International Inc | HOLD | 0 @ USD 21.73 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 21.73. The average price that BAX shares were previous bought at was USD 26.7919. The current market price is -18.9% lower than average price they were purchased at. USD 0 compared to the previous valuation of Baxter International Inc however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 207.39 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 207.39. The average price that BDX shares were previous bought at was USD 201.829. The current market price is 2.8% higher than average price they were purchased at. The value of the holding in BDX has fallen by USD 105,316 compared to the previous valuation of Becton Dickinson and Company |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 74.12 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 74.12. The average price that BSX shares were previous bought at was USD 97.948. The current market price is -24.3% lower than average price they were purchased at. The value of the holding in BSX has fallen by USD 445,293 compared to the previous valuation of Boston Scientific Corporation |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 74.12 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 74.12. The average price that BSX shares were previous bought at was USD 97.948. The current market price is -24.3% lower than average price they were purchased at. The value of the holding in BSX has fallen by USD 445,293 compared to the previous valuation of MULSTRXSSXIMETFP |
| CNMD - CONMED Corporation | HOLD | 0 @ USD 41.67 | USD 0 | The current share valuation price of CNMD based on adjusted close was USD 41.67. The average price that CNMD shares were previous bought at was USD 55.782. The current market price is -25.3% lower than average price they were purchased at. The value of the holding in CNMD has increased by USD 639 compared to the previous valuation of CONMED Corporation however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| DXCM - DexCom Inc | HOLD | 0 @ USD 70.16 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 70.16. The average price that DXCM shares were previous bought at was USD 74.9318. The current market price is -6.4% lower than average price they were purchased at. The value of the holding in DXCM has increased by USD 10,360 compared to the previous valuation of DexCom Inc however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| ENOV - Enovis Corp | HOLD | 0 @ USD 22.36 | USD 0 | The current share valuation price of ENOV based on adjusted close was USD 22.36. The average price that ENOV shares were previous bought at was USD 35.9397. The current market price is -37.8% lower than average price they were purchased at. The value of the holding in ENOV has fallen by USD 1,855 compared to the previous valuation of Enovis Corp |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 111.07 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 111.07. The average price that ABT shares were previous bought at was USD 128.029. The current market price is -13.2% lower than average price they were purchased at. The value of the holding in ABT has increased by USD 58,305 compared to the previous valuation of Abbott Laboratories however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 79.08 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 79.08. The average price that GEHC shares were previous bought at was USD 75.2973. The current market price is 5.0% higher than average price they were purchased at. The value of the holding in GEHC has fallen by USD 99,978 compared to the previous valuation of GE HealthCare Technologies Inc. |
| GKOS - Glaukos Corp | HOLD | 0 @ USD 113.27 | USD 0 | The current share valuation price of GKOS based on adjusted close was USD 113.27. The average price that GKOS shares were previous bought at was USD 108.13. The current market price is 4.8% higher than average price they were purchased at. The value of the holding in GKOS has increased by USD 6,052 compared to the previous valuation of Glaukos Corp however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| GMED - Globus Medical | HOLD | 0 @ USD 87.59 | USD 0 | The current share valuation price of GMED based on adjusted close was USD 87.59. The average price that GMED shares were previous bought at was USD 71.4406. The current market price is 22.6% higher than average price they were purchased at. The value of the holding in GMED has fallen by USD 3,424 compared to the previous valuation of Globus Medical |
| HOLX - Hologic Inc | HOLD | 0 @ USD 75.02 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 75.02. The average price that HOLX shares were previous bought at was USD 67.5461. The current market price is 11.1% higher than average price they were purchased at. The value of the holding in HOLX has increased by USD 6,543 compared to the previous valuation of Hologic Inc however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| IART - Integra LifeSciences Holdings | HOLD | 0 @ USD 10.93 | USD 0 | The current share valuation price of IART based on adjusted close was USD 10.93. The average price that IART shares were previous bought at was USD 17.5706. The current market price is -37.8% lower than average price they were purchased at. The value of the holding in IART has fallen by USD 3,063 compared to the previous valuation of Integra LifeSciences Holdings |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 639.79 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 639.79. The average price that IDXX shares were previous bought at was USD 518.716. The current market price is 23.3% higher than average price they were purchased at. The value of the holding in IDXX has fallen by USD 53,718 compared to the previous valuation of IDEXX Laboratories Inc |
| INSP - Inspirit Energy Holdings Plc | HOLD | 0 @ USD 66.33 | USD 0 | The current share valuation price of INSP based on adjusted close was USD 66.33. The average price that INSP shares were previous bought at was USD 132.878. The current market price is -50.1% lower than average price they were purchased at. The value of the holding in INSP has increased by USD 2,358 compared to the previous valuation of Inspirit Energy Holdings Plc however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 492.84 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 492.84. The average price that ISRG shares were previous bought at was USD 512.164. The current market price is -3.8% lower than average price they were purchased at. The value of the holding in ISRG has increased by USD 232,282 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2026-02-09 this would crystalise an overall loss. |
| ITGR - Integer Holdings Corp | HOLD | 0 @ USD 85.4599 | USD 0 | The current share valuation price of ITGR based on adjusted close was USD 85.4599. The average price that ITGR shares were previous bought at was USD 115.75. The current market price is -26.2% lower than average price they were purchased at. The value of the holding in ITGR has fallen by USD 4,803 compared to the previous valuation of Integer Holdings Corp |